DOSE OF REALITY: BIG PHARMA’S PATENT ABUSE COSTS AMERICAN PATIENTS OVER $40 BILLION IN JUST ONE YEAR

New Analysis Highlights Urgency to Hold Big Pharma Accountable for Egregious Anti-Competitive Practices Last week, The American Economic Liberties Project and the Initiative for Medicines, Access

05-23-2023 Read More

DOSE OF REALITY: BIG PHARMA TAX AVOIDANCE PRACTICES COME UNDER SCRUTINY IN SENATE FINANCE HEARING

Report Finds Big Pharma Games the System to Avoid Paying U.S. Taxes While Price-Gouging American Patients On Thursday, the U.S. Senate Finance Committee held a hearing titled

05-12-2023 Read More

THEY SAID IT! LAWMAKERS SLAM BIG PHARMA CEOS FOR EGREGIOUS PRICING OF BRAND NAME INSULINS

Brand Name Drug Giants Refuse to Rule Out Future Insulin Price Hikes On Wednesday, the U.S. Senate Committee on Health, Education, Labor and Pensions (HELP) held a hearing with executives from Big

05-12-2023 Read More

CSRXP COMMENDS HELP COMMITTEE FOR ADVANCING BIPARTISAN, MARKET-BASED SOLUTIONS TO HOLD BIG PHARMA ACCOUNTABLE

Senate Panel Passes Bills to Increase Competition and Increase List Price Transparency For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected] Washington

05-11-2023 Read More

CSRXP: SENATORS HAVE OPPORTUNITY TO PASS BIPARTISAN, MARKET-BASED SOLUTIONS TO HOLD BIG PHARMA ACCOUNTABLE

U.S. Senate HELP Committee Should Advance Legislation to Boost Competition and Increase List Price Transparency For Immediate Release Contact: Jon Conradi 860-235-3884 [email protected]

05-11-2023 Read More

DOSE OF REALITY: SENATORS MUST HOLD BIG PHARMA ACCOUNTABLE FOR EGREGIOUS INSULIN PRICING PRACTICES

Lawmakers Have Opportunity to Grill Big Pharma Executives on Tactics Like “Shadow Pricing” that Drove Crisis of Insulin Affordability On Wednesday, the U.S.

05-9-2023 Read More

BIG PHARMA EARNINGS WATCH: PFIZER, MODERNA, ELI LILLY, NOVARTIS, GLAXOSMITHKLINE, ROCHE, AMGEN

Brand Name Drug Companies Continue to Hike Prices and Post Record Profits Rounding out the rest of Big Pharma’s earnings calls for the first quarter, brand name drug makers Pfizer, Moderna, Eli

05-9-2023 Read More

CSRXP: MODERNA BRAZENLY IGNORES OUTRAGE BY MOVING AHEAD WITH EGREGIOUS VACCINE PRICE HIKE

Nearly 500 Percent Price Increase on Vaccine Developed with Taxpayer Investment Highlights Urgency to Hold Big Pharma Accountable For Immediate ReleaseContact: Jon

05-4-2023 Read More

BIG PHARMA EARNINGS WATCH: MERCK, SANOFI, BRISTOL MYERS SQUIBB, ABBVIE AND ASTRAZENECA

More Big Pharma Giants Surpass Wall Street Expectations, Buoyed By Egregious Price Hikes on Blockbuster Products to Start the Year Another round of first-quarter earnings reports from Merck, Sanofi,

05-3-2023 Read More

Sign-up for updates

  • This field is for validation purposes and should be left unchanged.